27 episodes

You've heard of thrombolysis? We are here to deliver anxiolysis when it comes to learning about stroke. We are a Stroke Educational podcast originally developed by a keen group of doctors in the Neurology program in Toronto. We are also the official podcast of the Canadian Stroke Consortium and will be releasing episodes with the prefix "CSC" to designate those podcasts. Ideas and opinions are our own and not any institution or hospital, and this podcast is not a substitute for expert medical advice. The purpose of this podcast is medical education. https://www.stroke.fm/the-team/disclaimer

Stroke FM Stroke FM

    • Health & Fitness
    • 5.0 • 10 Ratings

You've heard of thrombolysis? We are here to deliver anxiolysis when it comes to learning about stroke. We are a Stroke Educational podcast originally developed by a keen group of doctors in the Neurology program in Toronto. We are also the official podcast of the Canadian Stroke Consortium and will be releasing episodes with the prefix "CSC" to designate those podcasts. Ideas and opinions are our own and not any institution or hospital, and this podcast is not a substitute for expert medical advice. The purpose of this podcast is medical education. https://www.stroke.fm/the-team/disclaimer

    27 A Swell Simulation: debrief from a stroke simulation on angioedema

    27 A Swell Simulation: debrief from a stroke simulation on angioedema

    Welcome to StrokeFM Episode 27: In this exciting episode, we're taking you behind the scenes of our simulation session, where we grappled with angioedema in a code stroke. Explore with us as we delve into the intricacies of diagnosing and managing this life-threatening condition, learn from our successes and challenges, and gain insights from our team of expert cohosts. Whether you're a seasoned medical professional or starting your journey in health, you will want to experience this engaging journey into the heart of medical simulation training. This is a part of our ongoing efforts in a joint collaborative effort between Stroke and Emergency medicine. With that said, there is no duty of care. This is purely an educational podcast.



    In this exciting episode, join our expert panel @MirandaLambRN,  @LowylNotario, @emeduc, @neuroccm; we delve into the critical topic of Crisis Resource Management (CRM) in acute stroke care. In our podcast, we will apply these principles to a real-world scenario: managing a stroke emergency in the case of angioedema. The aim is to highlight the practical application of these CRM principles and discuss how they can facilitate consistent, safe, and efficacious care, helping to alleviate human factors and support high-performing teams. To make the transition from simulation to actual patient care as seamless as possible, thereby reducing stress, promoting certainty, and enhancing patient outcomes. So don't miss out. Tune in to our discussion to learn more about the transformative power of CRM in acute stroke care!



    StrokeFM is the Official Podcast of the CSC (⁠Canadian Stroke Consortium⁠), Founder and Producer Dr. Houman Khosravani ⁠@neuroccm⁠; Producer and Audio Engineer Dr. Jaime Cazes ⁠@JaimeCazes⁠.

    The music for this educational podcast is graciously provided by the musician ⁠breakmastercylinder⁠ ⁠@BrkmstrCylinder⁠ 

    As always, you abide by our Disclaimer statement by listening to this podcast. 



    #CrisisResourceManagement, #HighPerformingTeam

    Read our ⁠CRM manuscript⁠.

    • 34 min
    26 CSC StrokeFM Time to AcT

    26 CSC StrokeFM Time to AcT

    In this episode, we interview Dr. Bijoy Menon (PI) and Dr. Rick Swartz (Co-PI), and we delve into the AcT trial, a study conducted to evaluate the efficacy of tenecteplase compared to alteplase for treating acute ischemic stroke. The trial involved 1,600 participants, with a median follow-up duration of 97 days.

    The participants, who were all 18 years or older and had suffered an acute ischemic stroke within 4.5 hours of symptom onset, were randomly divided into two groups. Group one (816 patients) received intravenous tenecteplase (0.25 mg/kg, maximum of 25 mg), and group two (784 patients) received intravenous alteplase (0.09 mg/kg bolus, followed by a 60-minute infusion of the remaining 0.81 mg/kg).

    The primary outcome measured was the modified Rankin Scale score of 0 or 1, which indicates no significant disability. This was achieved by 36.9% of patients in the tenecteplase group compared to 34.8% in the alteplase group, establishing tenecteplase's noninferiority (p for superiority = 0.19).

    Secondary outcomes, such as intracerebral hemorrhage, were similar in both groups, with 3.4% in the tenecteplase group and 3.2% in the alteplase group.

    The conclusion drawn from the AcT trial is that tenecteplase was noninferior to alteplase in preserving neurological function in patients with acute ischemic stroke. Due to its ease of administration, tenecteplase may become a preferred treatment option.

    This episode is based on the study "Intravenous tenecteplase compared with alteplase for acute ischemic stroke in Canada (AcT): a pragmatic, multicenter, open-label, registry-linked, randomized, controlled, non-inferiority trial" published in Lancet in 2022.



    Disclaimer - StrokeFM is an Educational Podcast, by listening you understand that there is no duty of care, please read the full disclaimer.

    StrokeFM is the Official Podcast of the CSC (⁠Canadian Stroke Consortium⁠), Founder and Executive Producer Dr. Houman Khosravani ⁠@neuroccm⁠; Audio Engineer and Producer Dr. Jaime Cazes ⁠@JaimeCazes⁠.

    The music for this educational podcast is graciously provided by the musician ⁠breakmastercylinder⁠ ⁠@BrkmstrCylinder⁠

    • 49 min
    25 ThromboNeurology

    25 ThromboNeurology

    Welcome to StrokeFM Episode 25: ThromboNeurology - Bridging Stroke and Thrombosis Services for Enhanced Patient Care. In this episode, we explore the importance of fostering close collaboration between Stroke, Thrombosis, and Vascular Medicine disciplines. With overlapping diagnostic and treatment considerations and common underlying disorders and pathophysiology, there is immense potential for synergy and improved patient care through integrating these services.

    Listen in on insights provided by Stephanie Carlin (Thrombodsis Pharmacist, Hamilton) on the benefits of cross-pollination and training between thrombosis and stroke fellowship programs, share their experiences in leveraging existing expertise in vascular medicine, and provide insights into how centers in Canada/US, and other parts of the world can benefit by working closer together in collaboration between stroke and thrombosis programs.

    In addition to the insightful conversation, we have created a website and reference list strokeandthrombosis.org for background reading and resources to help you delve deeper into the topic. So, tune in to StrokeFM Episode 25: ThromboNeurology and join us on this journey towards a more collaborative and integrated approach to stroke and thrombosis care!



    StrokeFM is the Official Podcast of the CSC (⁠Canadian Stroke Consortium⁠), Founder and Executive Producer Dr. Houman Khosravani ⁠@neuroccm⁠; Audio Engineer and Producer Dr. Jaime Cazes ⁠@JaimeCazes⁠.

    The music for this educational podcast is graciously provided by the musician ⁠breakmastercylinder⁠ ⁠@BrkmstrCylinder⁠ 

    • 15 min
    24 Welcome to Season 3

    24 Welcome to Season 3

    Welcome to Season 3 of Stroke FM, where we continue our mission to bring you the best in stroke education. We are beyond excited to dive into a world where technology and stroke care intersect, exploring the fascinating realm of technology, Artificial Intelligence and its potential impact on stroke treatment and management.

    As always, our team is committed to delivering a series of captivating episodes that cover pragmatic topics across the spectrum. We'll discuss the latest breakthroughs, innovative approaches, and the most pressing challenges that professionals and patients face in stroke care.

    But that's not all! This season, we're also bringing together a stellar lineup of experts, thought leaders and industry insiders to share their insights and experiences. They'll provide you with invaluable knowledge and guidance and a glimpse into what the future holds for stroke care and technology.

    So, join us on this thrilling journey, and buckle up as we delve deeper into the captivating world of stroke education, technology, and care. Together, we'll uncover new ways to improve the lives of those affected by stroke and revolutionize how we approach stroke treatment.



    Ready to get started? Tune in to Stroke FM Season 3.



    StrokeFM is the Official Podcast of the CSC (⁠Canadian Stroke Consortium⁠), Founder and Executive Producer Dr. Houman Khosravani ⁠@neuroccm⁠; Audio Engineer and Producer Dr. Jaime Cazes ⁠@JaimeCazes⁠.

    The music for this educational podcast is graciously provided by the musician ⁠breakmastercylinder⁠ ⁠@BrkmstrCylinder⁠ 

    • 2 min
    23 SVIN2021 Talkin' Stroke & Enjoying desert sunsets

    23 SVIN2021 Talkin' Stroke & Enjoying desert sunsets

    The Society of Vascular and Interventional Neurology (SVIN) held its first Hybrid Annual Meeting November 17-20, 2021, virtually and on-site in Phoenix, AZ. It provided an opportunity for top-of-the-line education, networking opportunities, and discussions. Please visit their website: https://svin2021.com for further details and access to the conference. Become a member of SVIN and the CSC. In this episode, our host @neuroccm joins SVIN's new President Dr. Ameer Hassan @AmeerEHassan to discuss meeting highlights, and some key take-home messages from some of the great science presented at the meeting.
    Please follow us on Twitter: @strokefm
    Subscribe to the Podcast and give us 5 stars!
    Apple PodCast
    Spotify PodCast

    • 24 min
    22 CSC Stroke FM - To Serve and Protect: Neuroprotection in Stroke

    22 CSC Stroke FM - To Serve and Protect: Neuroprotection in Stroke

    This is an official Canadian Stroke Consortium (CSC) - StrokeFM Podcast episode:
    Neuroprotection and stroke care
    What does the future hold?  Where are we coming from and where are we going?  These and other exciting topics of discussion in conversation with Dr. Michael Hill (Calgary Stroke Program) as we chat about ESCAPE NA1 and ESCAPE NEXT. ESCAPE-NEXT is a multi-centre, randomized, double-blinded, placebo-controlled, parallel Group, single-dose trial designed to determine the efficacy and safety of Nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis. This is an official CSC Podcast episode (Season 2, Episode 8). As usual, see our Disclaimer about this educational podcast. 

    Please follow us on Twitter: @strokefm
    Subscribe to the Podcast and give us 5 stars!
    Apple PodCast
    Spotify PodCast

    • 34 min

Customer Reviews

5.0 out of 5
10 Ratings

10 Ratings

UC_student ,

Excellent podcast!

Informative, fun, engaging - excellent for learners in stroke!

Top Podcasts In Health & Fitness

Huberman Lab
Scicomm Media
On Purpose with Jay Shetty
iHeartPodcasts
Health Hacks with Mark Hyman, M.D.
OpenMind
Ten Percent Happier with Dan Harris
Ten Percent Happier
The School of Greatness
Lewis Howes
Nothing much happens: bedtime stories to help you sleep
iHeartPodcasts